In case you missed it: Aug 1 to Aug 5

Article

A look back at the week's news.

Cervical cancer screening guidelines for adolescents

Teenaged girls at average risk don’t need Papanicolaou tests, but some special populations do.

Finding the best fit

Best practices on discussing birth control for adolescents.

FDA grants ibrexafungerp sNDA priority review for RVVC

If approved, ibrexafungerp would be the first and only approved therapy for both the treatment of vulvovaginal candidiasis (VVC) and the prevention of recurrent vulvovaginal candidiasis (RVVC).

The latest resources from the American Urogynecologic Society

Check out these latest resources from the American Urogynecologic Society.

New ICD-10 codes to know before October

Changes for ICD-10 documentation codes that go into effect in October 2022.

How much money are you losing in unnecessary meetings?

Tips to avoid wasting time and optimize meetings you do need.

Recent Videos
1 expert is featured in this series.
Giovanni Traverso, PhD, highlights contraceptive implants through small needle | Image Credit: meche.mit.edu
Ryan Haumschild, PharmD
1 expert is featured in this series.
How sex differences impact treatment efficacy for chronic pain | Image Credit: profiles.ucalgary.ca.
Tuan Trang, PhD, discusses biological differences in chronic pain between men and women | Image Credit: profiles.ucalgary.ca.
1 expert is featured in this series.
How the Flyte device revolutionizes SUI management | Image Credit: linkedin.com.
Dr. Wanda Filer discusses how to overcome barriers to SUI treatment | Image Credit: linkedin.com.
Revi System shows efficacy against urgency urinary incontinence | Image Credit: ics.org.
Related Content
© 2025 MJH Life Sciences

All rights reserved.